Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmaq Analytiq AS
AS
Active
Org 982749042
Thormøhlens Gate 53D, 5006
Bergen
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 25 years old
57 employees
www.pharmaq-analytiq.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharmaq Analytiq AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NA
Nils Arne Grønlie
Chief Executive Officer
Chief Executive Officer
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
NA
Nils Arne Grønlie
Chairman
Chairman
2021
TA
Trine Astrid Vatle
Board of Directors
Board of Directors
2021
BB
Ben Backmann
Board of Directors
Board of Directors
2026
Former (1)
MK
Morten Kristoffer Nordstad
Deputy Chairman
Deputy Chairman
2016 – 2021
Shareholders
As of last annual report
Zoetis Netherlands 4 B.V. — 90.91%
Pharmaq Analytiq As — 9.09%
100%
Shareholder
Type
Ownership
Votes
Since
Zoetis Netherlands 4 B.V.
Company
90.91%
90.91%
2025
Pharmaq Analytiq As
Company
9.09%
9.09%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharmaq Analytiq AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network